Clinical Trial Update: Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the fluocinolone acetonide insert (ILUVIEN) for diabetic macular edema has been withdrawn. The sponsor listed is Johns Hopkins Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetic Macular Edema | Phase 4 | Status: WITHDRAWN